The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Probiotics, prebiotics, and postbiotics in health and disease
Open accessAbstract
The gut microbiota and its homeostasis play a crucial role in human health. However, for some diseases related to the gut microbiota, current traditional medicines can only relieve symptoms, and it is difficult to solve the root causes or even cause side effects like disturbances in the gut microbiota. Increasing clinical studies and evidences have demonstrated that probiotics, prebiotics, and postbiotics can prevent and treat various diseases, but currently they can only be used as dietary supplements rather than medicines, which restricts the application of probiotics in the field of medicine. Here, this review analyzes the importance of gut microbiota in human health and the current problems of traditional medicines, and systematically summarizes the effectiveness and mechanisms of probiotics, prebiotics, and postbiotics in maintaining health and treating diseases based on animal models and clinical trials. And based on current research outcomes and development trends in this field, the challenges and prospects of their clinical application in maintaining health, alleviating and treating diseases are analyzed. It is hoped to promote the application of probiotics, prebiotics, and postbiotics in disease treatment and open up new frontiers in probiotic research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–206 of 206
Probiotics: current regulatory aspects of probiotics for use in different disease conditions
Pogačar, M. Š., Mičetić‐Turk, D., & Fijan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00021-0 · Cited by 10
Types of fiber and gut microbiota composition and diversity among arab females
Aljuraiban, G. S., Algabsani, S., Sabico, S., Al-Shammari, S., Aljazairy, E. A., & Al-Musharaf, S. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103767 · Cited by 9
Diagnosis and management of pseudomembranous colitis and clostridium difficile- associated disease
Boardman, A. (1998) · Primary Care Update for OB/GYNS · doi:10.1016/s1068-607x(98)00154-1 · Cited by 8
Trends in modern drug discovery and development: A glance in the present millennium
Akram, M., Egbuna, C., Uche, C. Z., Chikwendu, C. J., Zafar, S., Rudrapal, M., Munir, N., Mohiuddin, G., Hannan, R., Ahmad, K. S., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90593-0.00008-3 · Cited by 5
Gut Remediation: Back to the Future
Ling, Z., Jiang, Y., & Li, X. (2020) · Springer eBooks · doi:10.1007/978-981-15-4759-1_7 · Cited by 3
Self-citationProbiotics and postbiotics: focus on metabolic syndrome
Gauffin-Cano, P., Marquez, A., Russo, M., Andrada, E., Mukdsi, M. C. A., & Medina, R. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823482-2.00025-x · Cited by 1
Cited by
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
Probiotic Functions in Fermented Foods: Anti-Viral, Immunomodulatory, and Anti-Cancer Benefits
Pyo, Y., Kwon, K. H., & Jung, Y. J. (2024) · Foods · doi:10.3390/foods13152386 · Cited by 66
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody
Lee, P.-J., Hung, C.-M., Yang, A.-J., Hou, C.-Y., Chou, H.-W., Chang, Y.-C., Chu, W.-C., Huang, W.-Y., Kuo, W.-C., Yang, C.-C., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2380061 · Cited by 33
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
Metadata
- Authors
- Ji, J., Jin, W., Liu, S., Jiao, Z., & Li, X.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2023-11-04
- Volume
- 4
- Issue
- 6
- Pages
- e420-e420
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W4388342205
- Cited by
- 384
- References
- 206
- FWCI
- 49.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.